Britain

The scientific work, published in the American Journal of Human Genetics, describes the clinical outcomes of seven patients from five different families, all with mutations in the gene called calmodulin-regulated spectrin-associated protein 1 (CAMSAP1) which causes this rare genetic disease. The genetic alterations in CAMSAP1 lead to abnormalities in neuronal structural proteins, which have an important role in regulating neuronal division and movement during brain development.

The delegation included Professor Peter Terpeni, a clinical geneticist, Professor Andrew Crosby, a human genome scientist, and Dr. Emma Babel, a clinical geneticist and scientist in genomic medicine and medical director of (South West Genomic Laboratory Hub).

They were received by Dr. Imad Dwaikat, the Dean of Faculty of Medicine, and Dr. Reham Khalaf Nazzal, Head of the Organs Functions and Medications Unit at the University.

The training was provided by a specialized staff from Otermans organization in London in addition to some other trainers from British Universities such as: University of Cambridge, University of Birmingham, Brunel University London, etc.

The training course focused on developing the practical skills in students in order to be able to prepare work reports in English, the right planning for projects, the modern ways in leading and working in teams, and prepare students to have their personal goals to get a position.